In-field stereotactic body radiotherapy (SBRT) reirradiation for pulmonary malignancies as a multicentre analysis of the German Society of Radiation Oncology (DEGRO)

Abstract Data of thoracic in-field reirradiation with two courses of stereotactic body radiotherapy (SBRT) is scarce. Aim of this study is to investigate feasibility and safety of this approach. Patients with a second course of thoracic SBRT and planning target volume (PTV) overlap were analyzed in...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Caroline John, Riccardo Dal Bello, Nicolaus Andratschke, Matthias Guckenberger, Judit Boda-Heggemann, Eleni Gkika, Frederick Mantel, Hanno M. Specht, Carmen Stromberger, Franz Zehentmayr, Oliver Blanck, Panagiotis Balermpas
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2021
Materias:
R
Q
Acceso en línea:https://doaj.org/article/97e6418881f24744aa53063fb62cee62
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:97e6418881f24744aa53063fb62cee62
record_format dspace
spelling oai:doaj.org-article:97e6418881f24744aa53063fb62cee622021-12-02T11:35:57ZIn-field stereotactic body radiotherapy (SBRT) reirradiation for pulmonary malignancies as a multicentre analysis of the German Society of Radiation Oncology (DEGRO)10.1038/s41598-021-83210-32045-2322https://doaj.org/article/97e6418881f24744aa53063fb62cee622021-02-01T00:00:00Zhttps://doi.org/10.1038/s41598-021-83210-3https://doaj.org/toc/2045-2322Abstract Data of thoracic in-field reirradiation with two courses of stereotactic body radiotherapy (SBRT) is scarce. Aim of this study is to investigate feasibility and safety of this approach. Patients with a second course of thoracic SBRT and planning target volume (PTV) overlap were analyzed in this retrospective, multicenter study. All plans and clinical data were centrally collected. 27 patients from 8 centers have been amenable for evaluation: 12 with non-small-cell lung cancer, 16 with metastases, treated from 2009 (oldest first course) to 2020 (latest second course). A median dose of 38.5 Gy to the 65%-isodose over a median of 5 fractions was prescribed in the first course and 40 Gy in 5 fractions for the second SBRT-course. Median PTV of the second SBRT was 29.5 cm3, median PTV overlap 22 cm3. With a median interval of 20.2 months between the two SBRT-courses, 1-year OS, and -LCR were 78.3% and 70.3% respectively. 3 patients developed grade 1 and one grade 2 pneumonitis. No grade > 2 toxicity was observed. Peripheral location and dose were the only factors correlating with tumor control. A second SBRT-course with PTV overlap appears safe and achieves reasonable local control.Caroline JohnRiccardo Dal BelloNicolaus AndratschkeMatthias GuckenbergerJudit Boda-HeggemannEleni GkikaFrederick MantelHanno M. SpechtCarmen StrombergerFranz ZehentmayrOliver BlanckPanagiotis BalermpasNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 11, Iss 1, Pp 1-11 (2021)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Caroline John
Riccardo Dal Bello
Nicolaus Andratschke
Matthias Guckenberger
Judit Boda-Heggemann
Eleni Gkika
Frederick Mantel
Hanno M. Specht
Carmen Stromberger
Franz Zehentmayr
Oliver Blanck
Panagiotis Balermpas
In-field stereotactic body radiotherapy (SBRT) reirradiation for pulmonary malignancies as a multicentre analysis of the German Society of Radiation Oncology (DEGRO)
description Abstract Data of thoracic in-field reirradiation with two courses of stereotactic body radiotherapy (SBRT) is scarce. Aim of this study is to investigate feasibility and safety of this approach. Patients with a second course of thoracic SBRT and planning target volume (PTV) overlap were analyzed in this retrospective, multicenter study. All plans and clinical data were centrally collected. 27 patients from 8 centers have been amenable for evaluation: 12 with non-small-cell lung cancer, 16 with metastases, treated from 2009 (oldest first course) to 2020 (latest second course). A median dose of 38.5 Gy to the 65%-isodose over a median of 5 fractions was prescribed in the first course and 40 Gy in 5 fractions for the second SBRT-course. Median PTV of the second SBRT was 29.5 cm3, median PTV overlap 22 cm3. With a median interval of 20.2 months between the two SBRT-courses, 1-year OS, and -LCR were 78.3% and 70.3% respectively. 3 patients developed grade 1 and one grade 2 pneumonitis. No grade > 2 toxicity was observed. Peripheral location and dose were the only factors correlating with tumor control. A second SBRT-course with PTV overlap appears safe and achieves reasonable local control.
format article
author Caroline John
Riccardo Dal Bello
Nicolaus Andratschke
Matthias Guckenberger
Judit Boda-Heggemann
Eleni Gkika
Frederick Mantel
Hanno M. Specht
Carmen Stromberger
Franz Zehentmayr
Oliver Blanck
Panagiotis Balermpas
author_facet Caroline John
Riccardo Dal Bello
Nicolaus Andratschke
Matthias Guckenberger
Judit Boda-Heggemann
Eleni Gkika
Frederick Mantel
Hanno M. Specht
Carmen Stromberger
Franz Zehentmayr
Oliver Blanck
Panagiotis Balermpas
author_sort Caroline John
title In-field stereotactic body radiotherapy (SBRT) reirradiation for pulmonary malignancies as a multicentre analysis of the German Society of Radiation Oncology (DEGRO)
title_short In-field stereotactic body radiotherapy (SBRT) reirradiation for pulmonary malignancies as a multicentre analysis of the German Society of Radiation Oncology (DEGRO)
title_full In-field stereotactic body radiotherapy (SBRT) reirradiation for pulmonary malignancies as a multicentre analysis of the German Society of Radiation Oncology (DEGRO)
title_fullStr In-field stereotactic body radiotherapy (SBRT) reirradiation for pulmonary malignancies as a multicentre analysis of the German Society of Radiation Oncology (DEGRO)
title_full_unstemmed In-field stereotactic body radiotherapy (SBRT) reirradiation for pulmonary malignancies as a multicentre analysis of the German Society of Radiation Oncology (DEGRO)
title_sort in-field stereotactic body radiotherapy (sbrt) reirradiation for pulmonary malignancies as a multicentre analysis of the german society of radiation oncology (degro)
publisher Nature Portfolio
publishDate 2021
url https://doaj.org/article/97e6418881f24744aa53063fb62cee62
work_keys_str_mv AT carolinejohn infieldstereotacticbodyradiotherapysbrtreirradiationforpulmonarymalignanciesasamulticentreanalysisofthegermansocietyofradiationoncologydegro
AT riccardodalbello infieldstereotacticbodyradiotherapysbrtreirradiationforpulmonarymalignanciesasamulticentreanalysisofthegermansocietyofradiationoncologydegro
AT nicolausandratschke infieldstereotacticbodyradiotherapysbrtreirradiationforpulmonarymalignanciesasamulticentreanalysisofthegermansocietyofradiationoncologydegro
AT matthiasguckenberger infieldstereotacticbodyradiotherapysbrtreirradiationforpulmonarymalignanciesasamulticentreanalysisofthegermansocietyofradiationoncologydegro
AT juditbodaheggemann infieldstereotacticbodyradiotherapysbrtreirradiationforpulmonarymalignanciesasamulticentreanalysisofthegermansocietyofradiationoncologydegro
AT elenigkika infieldstereotacticbodyradiotherapysbrtreirradiationforpulmonarymalignanciesasamulticentreanalysisofthegermansocietyofradiationoncologydegro
AT frederickmantel infieldstereotacticbodyradiotherapysbrtreirradiationforpulmonarymalignanciesasamulticentreanalysisofthegermansocietyofradiationoncologydegro
AT hannomspecht infieldstereotacticbodyradiotherapysbrtreirradiationforpulmonarymalignanciesasamulticentreanalysisofthegermansocietyofradiationoncologydegro
AT carmenstromberger infieldstereotacticbodyradiotherapysbrtreirradiationforpulmonarymalignanciesasamulticentreanalysisofthegermansocietyofradiationoncologydegro
AT franzzehentmayr infieldstereotacticbodyradiotherapysbrtreirradiationforpulmonarymalignanciesasamulticentreanalysisofthegermansocietyofradiationoncologydegro
AT oliverblanck infieldstereotacticbodyradiotherapysbrtreirradiationforpulmonarymalignanciesasamulticentreanalysisofthegermansocietyofradiationoncologydegro
AT panagiotisbalermpas infieldstereotacticbodyradiotherapysbrtreirradiationforpulmonarymalignanciesasamulticentreanalysisofthegermansocietyofradiationoncologydegro
_version_ 1718395834284900352